Patent application number | Description | Published |
20110299266 | AGGREGATOR FOR A SWITCH RACK SYSTEM - An aggregator for interconnecting a hydra with an breakout box, said aggregator comprising: (a) a bottom wall, two sides walls, and at least one faceplate; (b) adapters for multi-conductor connectors arranged in at least one column on said faceplate; and (c) wherein at least two adapters of each column are secure adapters. | 12-08-2011 |
20110299822 | SWITCH RACK SYSTEM - In one embodiment, the system comprises: (a) a chassis; (b) one or more cards mounted in the chassis, each card having a plurality of switch ports, the plurality of switch ports being aligned in one or more columns; (c) an aggregator mounted adjacent the chassis, the aggregator having a plurality of bays, each bay being aligned with a card in the chassis, at least one of the bays having a faceplate comprising at least first and second aggregator ports aligned in a column; (d) at least first and second hydras, wherein each hydra comprises at least (i) a first connector; (ii) a plurality of second connectors; (iii) a plurality of conductors, each conductor connecting the first connector to one of the second connectors, the plurality of conductors being bundled together to form a trunk portion from the first connector to a breakout point, the plurality of conductors being separated into breakout portions from the breakout point to the second connectors; (iv) wherein the trunk portion of the first cable is longer than that of the second cable; and (e) wherein the first connector of the first hydra is connected to the first aggregator port and the second connectors of the first hydra are connected to a first set of switch ports, and the first connector of the second hydra is connected to the second aggregator port and the second connectors of the second hydra are connected to a second set of switch ports, wherein the first set of switch ports are further away from the aggregator than the second set of switch ports. | 12-08-2011 |
20120145874 | METHOD AND APPARATUS FOR MOUNTING RACK COMPONENTS ON RACKS - The invention pertains to a system for mounting components to a rack comprising brackets that can be mounted to the rear of the rack through the opening in the front of rack before the component is inserted into the slot, which brackets fit into mating sleeves running along the sides of the components. The brackets include arms that extend forwardly towards the front of the slot. After the brackets are attached, the component can be slid into the slot from the front with the sleeves sliding over and engaging the brackets, thereby providing support for the component along a substantial portion of the depth of the component without the need to fixedly attach the component to the bracket after the component is in the rack. Accordingly, a component can be installed in a rack without the need for any access except from the front of the rack. | 06-14-2012 |
20140090867 | DEVICE AND METHOD FOR ROUTING CABLES - A cable routing device is provided for mounting and managing cables to telecommunications equipment. The cable routing device includes a support body with a plurality of cable channels defining a curved shape. A cable securing device secures the cables to the support body. The cable routing device can be mounted to the equipment after securement of the cables to the cable routing device. A variety of cable securing devices is provided including separate clips, hinged clips, and straps. Trunk cables can be mounted to the equipment, with cable breakouts extending into the equipment. The trunk cables transition from a vertical direction to a horizontal direction for entry into the equipment. | 04-03-2014 |
Patent application number | Description | Published |
20100009962 | Benzyl-substituted quinolone m1 receptor positive allosteric modulators - The present invention is directed to benzyl-substituted quinolone compounds of general formula (I) | 01-14-2010 |
20100216841 | 4-Fluoro-Piperidine T-Type Calcium Channel Antagonists - The present invention is directed to 4-fluoro-piperidine compounds which are antagonists of T-type calcium channels, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which T-type calcium channels are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels are involved. | 08-26-2010 |
20100222387 | 3-Fluoro-Piperidine T-Type Calcium Channel Antagonists - The present invention is directed to 3-fluoro-piperidine compounds which are antagonists of T-type calcium channels, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which T-type calcium channels are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels are involved. | 09-02-2010 |
20100317692 | Quinolone M1 Receptor Positive Allosteric Modulators - The present invention is directed to quinolone compounds of general formula (I) | 12-16-2010 |
20110077220 | 4-OXO,1-4-DIHYDROQUINOLINE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS - The present invention is directed to compounds of formula (I) which are M1 receptor positive allosteric modulators and that are useful in the treatment of diseases in which the M1 receptor is involved, such as Alzheimer's disease, schizophrenia, pain or sleep disorders. The invention is also directed to pharmaceutical compositions comprising the compounds, and to the use of the compounds and compositions in the treatment of diseases mediated by the M1 receptor. | 03-31-2011 |
20110212946 | Quinolone Neuropeptide S Receptor Antagonists - The present invention is directed to quinolone compounds which are antagonists of neuropeptide S receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which the neuropeptide S receptor is involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the neuropeptide S receptor is involved. | 09-01-2011 |
20130158056 | ALKOXY PYRIMIDINE PDE10 INHIBITORS - The present invention is directed to 2-alkoxy pyrimidine compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction. | 06-20-2013 |
20130203756 | ISOINDOLINE PDE10 INHIBITORS - The present invention is directed to isoindolinone compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction. | 08-08-2013 |
20140343053 | TRIAZOLOPYRIDINONE PDE10 INHIBITORS - The present invention is directed to triazolopyridinone compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction. | 11-20-2014 |
20150051248 | IMIDAZOLYL METHYL PIPERIDINE T-TYPE CALCIUM CHANNEL ANTAGONISTS - The present invention is directed to imidazolyl methyl piperidine compounds which are antagonists of T-type calcium channels, and which are useful in the treatment or prevention of disorders and diseases in which T-type calcium channels are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels are involved. | 02-19-2015 |